EOS imaging Reports Sharp 45% Increase in Revenues in the First Half of 2014
July 22 2014 - 1:20PM
Business Wire
Growth of 45% to €7.12 million in the
first half Excellent momentum in the second
quarter: up 65% to €4.96 million
Regulatory News:
EOS imaging (Euronext, FR0011191766 – EOSI – Eligible for PEA:
French SME Share Savings Schemes), the pioneer in 2D/3D medical
orthopedic imaging, today announced its consolidated half-year
revenues for the period ended June 30, 2014.
€m
June 30, 2014 June 30, 2013
% Change Sales of equipment
5.86 4.31
36% as a % of total revenues 82% 88% - Sales of
services
0.93 0.60 55% as a % of total revenues 13%
12% - Sales of consumables and related services
0.32
- n/a as a % of total revenues 5% -
Total revenues 7.12 4.91
45% Figures subject to limited review
- Sharp increase in sales in the first
half of 2014: up 45% to €7.12 million
The Company sold 15 EOS® systems during the first half, compared
to 11 during the same period last year. With a stable average
selling price of €391,000, revenues from sales of equipment totaled
€5.86 million, an increase of 36%.
Sales of services, which were driven by the increase in
installed equipment under contracts, rose by 55% to €0.93 million
compared with €0.60 million last year.
Sales of consumables and related services by the Company’s
OneFit Medical subsidiary amounted to €0.32 million in the first
half of 2014.
- The strong growth in international
sales was driven by momentum in Europe and Asia in the first half
of 2014
€m
June 30, 2014 June 30, 2013
% Change EMEA
3.22 2.28 41% North
America
1.18 2.63 -55% Asia Pacific
2.72
- n/a
Total revenues 7.12
4.91 45% Figures subject to limited review
EOS recorded excellent sales momentum in Asia during the first
half of 2014, which included the sale of seven systems, generating
revenues of €2.72 million.
The performance in Asia offset the impact of the downturn
recorded in the North American market, where sales decreased by 55%
to €1.18 million in the first half of 2014, compared with €2.63
million as at the end of June 2013.
EOS continued to register robust growth in the EMEA Region
(+41%), where it generated revenues of €3.22 million as compared to
€2.28 million last year.
- Acceleration in growth in the second
quarter of 2014: up 65% to €4.96 million
€m
2014 2013
Q1 Q2
Q1 Q2 Sales of equipment
1.56 4.30 1.60
2.71 as a % of total revenues 72% 87% 73%
90% Sales of services
0.45 0.48 0.30 0.30 as a
% of total revenues 21% 10% 27% 10% Sales of
consumables and related services
0.15 0.17 - - as a %
of total revenues 7% 3% - -
Total revenues
2.16 4.96 1.90 3.01
Figures subject to limited review
EOS imaging sold 11 EOS® systems in the second quarter of 2014
and generated revenues of €4.96 million, an increase of 65% as
compared to the second quarter of 2013.
Marie Meynadier, CEO of EOS imaging, made the following
comments: “Our positive half-year performance reflects the ongoing
adoption of our technology in new markets. Our excellent momentum
on the Asian and European markets enabled us to register strong
growth during the half-year despite a challenging environment for
capital equipment in the North American market. We are pursuing our
marketing strategy in order to ensure the increased adoption of EOS
in the three major markets where we currently operate.”
For more information, please visit www.eos-imaging.com.
About EOS imaging:
EOS imaging designs, develops, and markets EOS®, a revolutionary
and patented medical imaging system, based on technology that
enabled George Charpak to win the Nobel Prize for Physics. The
Company is authorized to market the system in 31 countries,
including the United States (FDA), Japan, Canada, Australia and the
European Union (EU). Backed by an installed base of 90 sites and
more than 400,000 imaging sessions, EOS® benefits from worldwide
recognition within the global medical community. As of December 31,
2013 the Group posted 2013 consolidated revenue of €15.2 million
and employed 101 people including an R&D team of 38 engineers.
The Group is based in Paris and holds four subsidiaries in Besançon
(France), Cambridge (Massachusetts), in Montreal (Canada) and
Frankfurt (Germany), and offices in Singapore. For further
information, please visit www.eos-imaging.com.
EOS imaging is listed on Compartment C of Euronext Paris
ISIN: FR0011191766 – Ticker: EOSI Next press release:
2014 first half results, on Sept. 1, 2014 (after market).
EOS imagingAnne RenevotCFOTel.: +33 (0)1 55
25 61 24investors@eos-imaging.comNewCapInvestor Relations
& Strategic CommunicationsSophie Boulila / Pierre LaurentTel.:
+33 (0)1 44 71 94 91eosimaging@newcap.frThe Ruth Group
(US)Press relationsMelanie Sollid-PentonPh:
646-536-7023msollid@theruthgroup.com
Eos (CE) (USOTC:EOSI)
Historical Stock Chart
From Apr 2024 to May 2024
Eos (CE) (USOTC:EOSI)
Historical Stock Chart
From May 2023 to May 2024